Page last updated: 2024-08-24

carbogen and Anemia

carbogen has been researched along with Anemia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bijl, HP; Bussink, J; Chin, A; de Bree, R; Doornaert, PA; Hoogsteen, IJ; Janssens, GO; Kaanders, JH; Rademakers, SE; Span, PN; Takes, RP; Terhaard, CH; van den Ende, P	1
Hoogsteen, IJ; Kaanders, JH; Marres, HA; van der Kogel, AJ	1
de Serdio, JL; Martinez, JC; Villar, A	1
Koch, CJ; Lee, J; Lord, EM; Siemann, DW	1
Artazkoz, JJ; Borque, C; Cabezon, MA; de Serdio, JL; Espiñeira, M; Fuentes, C; Gil, J; Martinez, JC; Perez, MD; Saavedra, JA; Suñer, M; Villar, A	1

Reviews

1 review(s) available for carbogen and Anemia

Article	Year
The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clinical oncology (Royal College of Radiologists (Great Britain)), 2007, Volume: 19, Issue:6 Topics: Anemia; Biomarkers, Tumor; Carbon Dioxide; Cell Hypoxia; Humans; Hyperbaric Oxygenation; Neoplasms; Niacinamide; Nuclear Medicine; Oxygen; Patient Selection; Radiation Tolerance; Radiation-Sensitizing Agents; Vitamin B Complex	2007

Article

Year

The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2007, Volume: 19, Issue:6

Topics: Anemia; Biomarkers, Tumor; Carbon Dioxide; Cell Hypoxia; Humans; Hyperbaric Oxygenation; Neoplasms; Niacinamide; Nuclear Medicine; Oxygen; Patient Selection; Radiation Tolerance; Radiation-Sensitizing Agents; Vitamin B Complex

2007

Trials

2 trial(s) available for carbogen and Anemia

Article	Year
Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Mar-01, Volume: 20, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anemia; Biomarkers; Carbon Dioxide; Female; Hemoglobins; Humans; Hypoxia; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Oxygen; Prognosis; Radiation-Sensitizing Agents; Radiotherapy; Treatment Outcome	2014
Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer. International journal of radiation oncology, biology, physics, 2001, May-01, Volume: 50, Issue:1 Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Erythrocyte Transfusion; Erythropoietin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation-Sensitizing Agents; Survival Rate	2001

Article

Year

Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Mar-01, Volume: 20, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Anemia; Biomarkers; Carbon Dioxide; Female; Hemoglobins; Humans; Hypoxia; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Oxygen; Prognosis; Radiation-Sensitizing Agents; Radiotherapy; Treatment Outcome

2014

Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer.

International journal of radiation oncology, biology, physics, 2001, May-01, Volume: 50, Issue:1

Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Erythrocyte Transfusion; Erythropoietin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation-Sensitizing Agents; Survival Rate

2001

Other Studies

2 other study(ies) available for carbogen and Anemia

Article	Year
Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction wi International journal of radiation oncology, biology, physics, 2008, Apr-01, Volume: 70, Issue:5 Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Carcinoma, Squamous Cell; Clinical Protocols; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Erythropoietin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation Injuries; Radiation-Sensitizing Agents; Recombinant Proteins; Salvage Therapy	2008
Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. International journal of cancer, 1996, Jul-29, Volume: 67, Issue:3 Topics: Anemia; Animals; Antibodies, Monoclonal; Carbon Dioxide; Cell Hypoxia; Cell Survival; Etanidazole; Female; Flow Cytometry; Fluorescent Antibody Technique; Hydralazine; Hydrocarbons, Fluorinated; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Oxygen; Phenylhydrazines; Radiobiology; Sarcoma, Experimental; Vasodilator Agents	1996

Article

Year

Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction wi

International journal of radiation oncology, biology, physics, 2008, Apr-01, Volume: 70, Issue:5

Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Carcinoma, Squamous Cell; Clinical Protocols; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Erythropoietin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation Injuries; Radiation-Sensitizing Agents; Recombinant Proteins; Salvage Therapy

2008

Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.

International journal of cancer, 1996, Jul-29, Volume: 67, Issue:3

Topics: Anemia; Animals; Antibodies, Monoclonal; Carbon Dioxide; Cell Hypoxia; Cell Survival; Etanidazole; Female; Flow Cytometry; Fluorescent Antibody Technique; Hydralazine; Hydrocarbons, Fluorinated; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Oxygen; Phenylhydrazines; Radiobiology; Sarcoma, Experimental; Vasodilator Agents

1996